Profile
Company facts
- Exchange
- NSE
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- ISIN
- INE03QK01018
- Market cap
- 413B
- P/E ratio
- 99.01
- Analyst target
- 1396.6666
- Dividend yield
- Not available
- Beta
- 1.13
About
About Suven Pharmaceuticals Limited
Cohance Lifesciences Limited engage in the end-to-end contract development and manufacturing of intermediates and active pharmaceutical ingredients in India. The coampny offers active pharmaceutical ingredients and formulations for various applications; CDMO services, a flexible and custom solutions for challenging development and manufacturing needs; and clinical, analytical, and research services. It also manufactures finished dosage formulations for pharmaceutical companies; and specialty chemicals, such as electronic chemicals. The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025. The company was founded in 1989 and is based in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.
Visit company website
5 years, 5 months ago
Suven Pharmaceuticals Limited is currently in a long term uptrend where the price is trading 4.2% above its 200 day moving average.
From a valuation standpoint, the stock is 179.9% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 13.4.
Based on the above factors, Suven Pharmaceuticals Limited gets an overall score of 1/5.